Bittencourt LK, Guricova K, Zucker I, Durieux JC, et al. Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-naive men: a large cohort validation study. Eur Radiol 2022 Jan 14. pii: 10.1007/s00330-021-08407.
PMID: 35028750